New drug may help sick kids' blood flow better than standard treatment
NCT ID NCT07519226
First seen Apr 21, 2026 · Last updated Apr 29, 2026 · Updated 1 time
Summary
This study tested a drug called penehyclidine hydrochloride in 98 critically ill children with shock. The goal was to see if it could improve tiny blood vessel function better than the usual medicine, atropine. Children were eligible if their blood pressure was normal but they still had signs of poor blood flow, like slow capillary refill or high lactate levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.